Lymphocyte activation in the pathogenesis of psoriasis

Journal of Investigative Dermatology

Volumn 109, Issue 1, 1997, Pages 1-4

  Norris, D A ^a   Travers, J B ^a   Leung, D Y M ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 2 RECEPTOR; T LYMPHOCYTE RECEPTOR;

ANTIGEN EXPRESSION; CELL PROLIFERATION; CELL REGENERATION; EDITORIAL; ENDOTHELIUM CELL; EPIDERMIS CELL; KERATINOCYTE; PRIORITY JOURNAL; PSORIASIS; SKIN INFLAMMATION; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION;

EID: 0030746705     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1111/1523-1747.ep12276285     Document Type: Editorial

References (30)

1. D.S. Baker A.F. Swain L. Fry H. Valdimarsson Epidermal T lymphocytes and HLA-DR. expression in psoriasis Br J Dermatol 110 1984 555 564
2. B.S. Baker S. Bokch A. Powles J.J. Garioch H. Lewis H. Valdimarsson L. Fry Group A streptococcal antigen-specific T lymphocytes in guttate psoriatic lesions Br J Dermatal 128 1993 493 499
3. J.N. Barker G.D. Karabin T.J. Stoof V.J. Sarma V.M. Dixit B.J. Nickoloff Detection of interferon- γ -mRNA in psoriatic epidermis by polymerase chain reaction J Dermatol Sci 2 1991 106 111
4. W.H. Boehncke D. Dressel H. Manfras T.M. Zollner A. Wettstein B.O. Bohm W. Sterry T-cell-receptor repertoire in chronic plaque-stage psoriasis is restricted and lacks enrichment of superantigen-associated V β regions J Invest Dermatol 104 1995 725 728
5. W.H. Boehncke D. Dressel T.M. Zollner R. Kaufinann Pulling the trigger on psoriasis (letter) Nature 379 1996 777
6. J.C. Chang L.R. Smith K.J. Froning B.J. Schwabe J.A. Laxer L.L. Caralli H.H. Kurland M.A. Karasek D.I. Wilkinson D.J. Carlo CD8+ T cells in psoriatic lesions preferentially use T-cell receptor V β 3 and/or V β 13.1 genes Proc Natl Acad Sci (USA) 91 1994 9282 9286
7. M. Detmar L.F. Brown K.P. Claffey K.T. Yeo O. Kocher R.W. Jackman B. Berse H.F. Dvorak Overexpression of vascular permeability factor/vascular endothelial growth factor and its receptors in psoriasis J Exp Med 180 1994 1141 1146
8. Y.V. Ezepechuk D.Y.M. Leung M.H. Middleton P. Bina R. Reiser D.A. Morris Staphylococcal toxins and protein A differentially induce cytotoxicity and release of minor necrosis factor- α from human keratinocytes J Invest Dermatol 107 1996 603 609
9. S.L. Gottlieb P. Gilleaudeau R. Johnson L. Estes T.G. Woodworth A.B. Gottlieb J.G. Krueger Response of psoriasis to a lymphocyte-selective toxin (DAB389IL-2) suggests a primary immune, but not a keratinocyte, pathogenesis Nature Med 1 1995 442 447
10. A.K. Gupta C.N. Ellis B.J. Nickoloff M.T. Goldfarb V.C. Ho L.L. Rocher C.E. Griffiths K.D. Cooper J.J. Voorhees Oral cyclosporine in the treatment of inflammatory and noninflammatory dermatoses. A clinical and immunopathologic analysis Arch Dermatol 126 1990 339 350
11. R.S. Kalish K.L. Johnson Enrichment and function of uroshiol (poison-ivy)-specific T lymphocytes in lesions of allergic contact dermatitis to uroshiol J Immunol 145 1990 3706 3713
12. T. Kojima M.A. Cromie G.J. Fisher J.J. Voorhees J.T. Elder GRO- α mRNA is selectively overexpressed in psoriatic epidermis and is reduced by cyclosporin A in vivo, but not in cultured keratinocytes J Invest Dermatol 101 1993 767 772
13. D.Y. Leung P. Walsh R. Giorno D.A. Norris A potential role for superantigens in the pathogenesis of psoriasis J Invest Dermatol 100 1993 225 228
14. D.Y. Leung M. Gately A. Trumble B. Darnell P.M. Schlievert L.J. Picker Bacterial superantigens induce T-cell expression of the skin-selective homing receptor, the cutaneous lymphocyte-associated antigen, via stimulation of interleukin 12 production J Exp Med 181 1995 747 753
15. D.Y. Leung J.B. Travers R. Giorno D.A. Norris R. Skinner J. Aelion L.V. Kazemi M.H. Kim A.E. Trumble M. Kotb Evidence for a streptococcal supcrantigen-driven process in acute guttate psoriasis J Clin Invest 96 1995 2106 2112
16. H.M. Lewis B.S. Baker S. Bokth A.V. Powles J.J. Garioch H. Valdimarsson L. Fry Restricted T-cell receptor Vâ gene usage in the skin of patients with guttate and chronic plaque psoriasis Br J Dermatol 129 1993 514 520
17. R.T. McCluskey B. Benacerraf J.W. McCluskey Studies on the specificity of the cellular infiltrate in delayed hypersensitivity reactions J Exp. Med 90 1963 466 477
18. A. Menssen P. Trommler S. Vollmer D. Schendel E. Albert L. Gurtler G. Riethmuller J.C. Prinz Evidence for an antigen-specific cellular immune response in skin lesions of patients with psoriasis vulgaris J Immunol 155 1995 4078 4083
19. P. Moss P. Charmley E. Mulbihill S. Ziegler G.J. Rangi D. Kern M. Piepkorn R. Gelinas The repertoire of T cell antigen receptor β -chain variable regions associated with psoriasis vulgaris J Invest Dermatol 109 1997 14 19
20. D.A. Norris D.Y.M. Leung The role of superantigens in skin disease D.Y.M.D. Leung B.T. Huber P.M. Schlievert The Role of Superantigens in Inflammatory Skin Diseases 1997 Marcel Dekker New York in press
21. D. Parent B.A. Bernard C. Desbas M. Heenen M.Y. Darmon Spreading of psoriatic plaques: alteration of epidermal differentiation precedes capillary leakiness and anomalies in vascular morphology J Invest Dermatol 95 1990 333 340
22. M. Schmitt-Egenolf W.H. Boehncke E. Christophers M. Stander W. Sterry Type I and type II psoriasis show a similiar usage of T-cell receptor variable regions J Invest Dermatol 97 1991 1053 1056
23. M.P. Schon M. Detmar C.M. Parker Murine psoriasis-like disorder induced by naive CD4+ T cells Nature Med 3 1997 183 188
24. P. Strange K.D. Cooper E.R. Hausen G. Fisher J.K. Larsen D. Fox C. Krag J.J. Voorhees O. Baadsgaard T-lymphocyte clones initiated from lesional psoriatic skin release groowth factors that induce keratinocyte proliferation J Invest Dermatol 101 1993 695 700
25. K. Uyemura M. Yamamamura D.F. Fivenson R.L. Modlin B.J. Nickoloff The cytokine network in lesional and lesion-tree psoriatic skin is characterized by a T-helper type 1 cell-mediated response J Invest Dermatol 101 1993 701 705
26. H. Valdimarsson B.S. Baker I. Jonsdottir A. Powles L. Fry Psoriasis: a T-cell-mediated autoimmune disease induced by streptococcal superantigens? Immunol Today 16 1995 145 149
27. V.P. Vallat P. Gilleaudeau L. Battat J. Wolfe R. Nabeya N. Haytler E. Hodak A.B. Gottlieh J.G. Krueger PUVA bath therapy strongly suppresses immunological and epidermal activation in psoriasis: a possible cellular basis for remittive therapy J Exp Med 180 1994 283 296
28. M.A. Vekony J.E. Holder A.J. Lee C. Horrocks I.C. Eperon R.D.R. Camp Selective amplification of T-cell receptor variable region species is demonstrable but not essential in early lesions of psoriasis vulgaris: analysis by anchored polymerase chain reaction and hypervariable region size spectratyping J Invest Dermatol 109 1997 5 13
29. S. Vollmer A. Menssen P. Trommler D. Schendel J.C. Prinz T lymphocytes derived from skin lesions of patients with psoriasis vulgaris express a novel cytokine pattern that is distinct from that of T helper type I and T helper type II cells Eur J Immunol 24 1994 2377 2382
30. T. Wrone-Smith B.J. Nickoloff Dermatol injection of immunocytes induces psoriasis J Clin Invest 98 1996 1878 1887